The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V08 | Contrast media | |
| 3 | V08C | Magnetic resonance imaging contrast media | |
| 4 | V08CA | Paramagnetic contrast media | |
| 5 | V08CA05 | Mangafodipir |
| Active Ingredient | Description | |
|---|---|---|
| Mangafodipir |
Mangafodipir is a chelate containing the metal manganese – which has paramagnetic properties and is responsible for the contrast enhancement effect in MRI – and the ligand fodipir (dipyridoxyl diphosphate). Manganese is preferentially taken up by normal liver parenchyma and also in the pancreas so that contrast enhancement between abnormal and normal tissue can be expected. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TELESCAN Solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
